Profil bibliographique

Delphine Lebon

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

146Publications signalées

1012Citations signalées

2Affiliations récentes

Institutions déclarées

Centre Hospitalier Universitaire Amiens-Picardie Université de Picardie Jules Verne

Domaines associés

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and Treatments

Publications récentes

2026 articleOpenAlex

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort

Lin‐Pierre Zhao, Céline Berthon, Laurène Fenwarth, Stéphane de Botton et autres

0 citationsLeukemia

2026 articleOpenAlex

POSTER: AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

AML-477: The Efficacy of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

POSTER: AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 articleOpenAlex

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Augustin Boudry, Laurène Fenwarth, Raphael Itzykson, Thorsten Braun et autres

0 citationsBlood Cancer Journal

2026 articleOpenAlex

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement

Benoît Ducourneau, Arnaud Pagès, Stéphanie Struski, Matthieu Décamp et autres

0 citationsLeukemia

Accès ouvert 2026 articleOpenAlex

B‐Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly‐Derived Mesenchymal Stem Cells

Louison Collet, Hakim Ouled‐Haddou, Hussein Ghamlouch, Walaa Darwiche et autres

1 citationEuropean Journal of Immunology

2026 articleOpenAlex

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez, E. Raffoux et autres

1 citationLeukemia

2026 peer-reviewOpenAlex

Author response for "B-cell differentiation of human hematopoietic progenitors is efficiently supported by Wharton jelly-derived mesenchymal stem cells"

Louison Collet, Hakim Ouled‐Haddou, Hussein Ghamlouch, Walaa Darwiche et autres

0 citations

2026 articleOpenAlex

Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection

Aurélien Aubry, Magalie Joris, Morgane Choquet, Hélène Kemp et autres

0 citationsEuropean Journal of Clinical Microbiology & Infectious Diseases

Accès ouvert 2026 articleOpenAlex

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane et autres

6 citationsJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.